US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Artelo Biosciences Inc (ARTL)
Artelo Biosciences Inc (ARTL) ニュース

ARTL

Artelo Biosciences (ARTL)

Artelo Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARTL

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/23	21 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy	NASDAQ:ARTL	Artelo Biosciences Inc
2024/04/22	21 : 30	GlobeNewswire Inc.	Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time	NASDAQ:ARTL	Artelo Biosciences Inc
2024/03/25	21 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2024/03/12	22 : 15	GlobeNewswire Inc.	Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge	NASDAQ:ARTL	Artelo Biosciences Inc
2024/01/23	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy	NASDAQ:ARTL	Artelo Biosciences Inc
2024/01/08	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12	NASDAQ:ARTL	Artelo Biosciences Inc
2023/12/05	22 : 30	GlobeNewswire Inc.	Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/30	23 : 00	GlobeNewswire Inc.	Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germany	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/13	22 : 02	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/13	22 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/09	23 : 00	GlobeNewswire Inc.	Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain Cancers	NASDAQ:ARTL	Artelo Biosciences Inc
2023/11/02	21 : 30	GlobeNewswire Inc.	Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023	NASDAQ:ARTL	Artelo Biosciences Inc
2023/10/04	21 : 30	GlobeNewswire Inc.	Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and Cachexia	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/13	21 : 30	GlobeNewswire Inc.	Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20th	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/07	21 : 00	GlobeNewswire Inc.	Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/06	22 : 00	GlobeNewswire Inc.	Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12th	NASDAQ:ARTL	Artelo Biosciences Inc
2023/09/05	22 : 00	GlobeNewswire Inc.	Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13th	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/10	21 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/10	21 : 00	GlobeNewswire Inc.	Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/09	05 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARTL	Artelo Biosciences Inc
2023/08/09	05 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/19	22 : 00	GlobeNewswire Inc.	Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/17	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/10	21 : 30	GlobeNewswire Inc.	Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/07	21 : 23	Edgar (US Regulatory)	Form DEL AM - Delaying amendment	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/07	05 : 31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/04	03 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ARTL	Artelo Biosciences Inc
2023/07/04	03 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ARTL	Artelo Biosciences Inc
2023/06/28	21 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium	NASDAQ:ARTL	Artelo Biosciences Inc
2023/06/27	21 : 30	GlobeNewswire Inc.	Artelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society Symposium	NASDAQ:ARTL	Artelo Biosciences Inc

Showing the most relevant articles for your search:NASDAQ:ARTL

1 2 3 4 5 6 7 次へ >>

Invesco QQQ Trust Series 1

US Dollar vs Euro

US Dollar vs Sterling

Deutsche Telekom (QX)

Bank of America

JP Morgan Chase

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約